Treatment of Hypertensive Emergencies with Sodium Nitroprusside

1970 ◽  
Vol 4 (7) ◽  
pp. 187-189 ◽  
Author(s):  
Larry Cacace ◽  
Terry Thomas
2020 ◽  
Vol 2 (5) ◽  
pp. 522-525 ◽  
Author(s):  
Guido Bothof ◽  
Koen P. van Rhee ◽  
Erik Koomen ◽  
Esther S. Veldhoen

Abstract The aim of this brief communication is to provide a short overview of cyanide intoxication following infusion of sodium nitroprusside (SNP). SNP is a fast-acting antihypertensive drug frequently used in of hypertensive emergencies. Although SNP is widely known as a safe to use drug, it can cause a potentially lethal cyanide intoxication. The difficulty to diagnose cyanide intoxication and pharmacological principles will be discussed. Hereby, we like to regain attention for this severe complication. As a result of our experience, the Dutch national paediatric drug formulary has been updated with additional warnings and recommendations. Cyanide intoxication due to sodium nitroprusside is a severe and difficult to recognize complication with potentially lethal outcome. Clinicians prescribing sodium nitroprusside should always be aware of its toxic effects.


1967 ◽  
Vol 5 (12) ◽  
pp. 47-48

Sodium nitroprusside was first used in hypertension by Page and his colleagues1 on the basis of previous work in dogs. Its antihypertensive activity is much greater than that of the nitrite ion. The drug directly dilates peripheral arteries. This action does not depend on an intact autonomic nerve supply, and can be demonstrated as well on isolated arteries as in the whole animal.


1997 ◽  
Vol 23 (8) ◽  
pp. 885-888 ◽  
Author(s):  
M. M. Hirschl ◽  
M. Binder ◽  
A. Bur ◽  
H. Herkner ◽  
M. Müllner ◽  
...  

1997 ◽  
Vol 78 (04) ◽  
pp. 1242-1248 ◽  
Author(s):  
David E Newby ◽  
Robert A Wright ◽  
Christopher A Ludlam ◽  
Keith A A Fox ◽  
Nicholas A Boon ◽  
...  

SummaryThe effects on blood flow and plasma fibrinolytic and coagulation parameters of intraarterial substance P, an endothelium dependent vasodilator, and sodium nitroprusside, a control endothelium independent vasodilator, were studied in the human forearm circulation. At subsystemic locally active doses, both substance P (2-8 pmol/min) and sodium nitroprusside (2-8 μg/min) caused dose-dependent vasodilatation (p <0.001 for both) without affecting plasma concentrations of PAI-1, von Willebrand factor antigen or factor VIII:C activity. Substance P caused local increases in t-PA antigen and activity (p <0.001) in the infused arm while sodium nitroprusside did not. At higher doses, substance P increased blood flow and t-PA concentrations in the noninfused arm. We conclude that brief, locally active and subsystemic infusions of intraarterial substance P cause a rapid and substantial local release of t-PA which appear to act via a flow and nitric oxide independent mechanism. This model should provide a useful and selective method of assessing the in vivo capacity of the forearm endothelium to release t-PA acutely.


Sign in / Sign up

Export Citation Format

Share Document